• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

270.8955 USD 4.3345 1.57%

As of 14:39:52 ET on 09/22/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 275.2100 High - Low: 275.2200 - 270.1101 Primary Exchange: NASDAQ GM
Volume: 899,527 52-Week Range: 191.2903 - 278.7800 Beta vs XNBI: 1.0000

ETF Chart for IBB

No chart data available.
  • IBB:US 270.8000
  • 1D
  • 1M
  • 1Y
275.2300
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-09-19) 275.2900
Assets (M) (on 2014-09-19) 5,395.6920
Shares out (M) 19.60
Market Cap (M) 5,306.50
% Premium -0.02
Average 52-Week % Premium -0.0006
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month +2.99% 1-Year +30.44%
3-Month +10.01% 3-Year +41.54%
Year To Date +21.40% 5-Year +27.50%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 09/18/2014
Name Position Value % of Total
Gilead Sciences Inc 4,736,268 501,712,869 9.257%
Amgen Inc 3,316,092 470,951,386 8.690%
Celgene Corp 5,026,882 468,857,284 8.651%
Biogen Idec Inc 1,204,342 397,420,817 7.333%
Alexion Pharmaceuticals Inc 2,114,010 341,539,456 6.302%
Vertex Pharmaceuticals Inc 2,661,447 259,091,865 4.781%
Regeneron Pharmaceuticals Inc 626,521 227,264,228 4.193%
Illumina Inc 1,215,277 216,222,084 3.990%
Mylan Inc/PA 3,858,665 186,875,146 3.448%
Endo International PLC 1,752,845 117,335,444 2.165%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil